Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Seres Therapeutics Inc (MCRB)

  • Event
  • Aug. 03, 2022, 11:15 UTC
  • 12
  • 1 comments

(30% Negative) SERES THERAPEUTICS, INC. (MCRB) Reports Q3 2022 Financial Results

Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Event
  • Aug. 03, 2022, 11:15 UTC
  • 12
  • 1 comments

(30% Negative) Aclaris Therapeutics, Inc. (ACRS) Reports Q3 2022 Financial Results

Comment Full text

Amarin Corporation Plc (AMRN)

  • Event
  • Aug. 03, 2022, 11:08 UTC
  • 12
  • 1 comments

(30% Negative) AMARIN CORP PLC\UK (AMRN) Reports Q3 2022 Financial Results

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • Event
  • Aug. 03, 2022, 11:08 UTC
  • 12
  • 1 comments

(10% Negative) REGENERON PHARMACEUTICALS, INC. (REGN) Reports Q3 2022 Financial Results

Comment Full text

EyePoint Pharmaceuticals Inc (EYPT)

  • Event
  • Aug. 03, 2022, 11:07 UTC
  • 12
  • 1 comments

(30% Negative) EyePoint Pharmaceuticals, Inc. (EYPT) Reports Q3 2022 Financial Results

Comment Full text

Horizon Therapeutics plc (was acquisited by Amgen (NASDAQ: AMGN)) (HZNP)

  • Event
  • Aug. 03, 2022, 11:06 UTC
  • 12
  • 1 comments

(10% Negative) Horizon Therapeutics Public Ltd Co (HZNP) Reports Q3 2022 Financial Results

Comment Full text

Moderna Inc (MRNA)

  • Event
  • Aug. 03, 2022, 11:04 UTC
  • 12
  • 1 comments

(30% Negative) MODERNA, INC. (MRNA) Reports Q3 2022 Financial Results

Comment Full text

Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)

  • Event
  • Aug. 03, 2022, 11:00 UTC
  • 12
  • 1 comments

(10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Reports Q3 2022 Financial Results

Comment Full text

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Aug. 03, 2022, 10:51 UTC
  • 12
  • 1 comments

(30% Negative) Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF) Reports Q3 2022 Financial Results

Comment Full text

Editas Medicine Inc (EDIT)

  • Event
  • Aug. 03, 2022, 10:46 UTC
  • 12
  • 1 comments

(30% Negative) Editas Medicine, Inc. (EDIT) Reports Q3 2022 Financial Results

Comment Full text
  • Previous
  • 139
  • 140
  • 141
  • 142
  • 143
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2258)
  • SEC News(189208)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124562)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin